Results

1–4 of 4 results for compliance

Outcomes of Patients With Proliferative Diabetic Retinopathy Treated With Anti-VEGF Therapy and/or PRP in the United States Who Were Lost to Follow-up
Rahul N. Khurana, MD, FASRS
Annual Meeting Talks
2025
Intended vs Actual Intervals Between Intravitreal Anti-VEGF Injections and Assessment of Treatment Delays
Christina Y Weng, MD, MBA, FASRS
Annual Meeting Talks
2023
Complications, Compliance, and 2-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for PDR-Related Vitreous Hemorrhage
Dennis M. Marcus, MD
Annual Meeting Talks
2020
Deferred Compensation? Tax Cuts and the Jobs Act What You Need to Know
Robert C. Wang, MD, FASRS
Updates from the Field
2018